private:aescapventure
|
218794
|
Dec 3rd, 2020 12:00AM
|
Aescap
|
247
|
10.00
|
Open
|
Investment Management
|
Dec 3rd, 2020 08:43AM
|
Dec 3rd, 2020 08:43AM
|
Aescap invests in public medical companies, also called biotech or life sciences companies, from their offices in Amsterdam, the Netherlands. It's latest fund, Aescap 2.0, manages over 200 million euro and has a long term outperformance of its bench mark, the Nasdaq Biotech Index. Aescap 2.0 has the highest Morningstar rating (5-stars)
|
Open
|
biotech, fund management, life sciences
|
Open
|
Barbara Strozzilaan 101
|
Amsterdam
|
North Holland
|
NL
|
1083HN
|
|
Aescap Venture
|
|
Financial Services
|
private:aescapventure
|
218794
|
Dec 2nd, 2020 12:00AM
|
Aescap
|
247
|
10.00
|
Open
|
Investment Management
|
Dec 2nd, 2020 10:38AM
|
Dec 2nd, 2020 10:38AM
|
Aescap invests in public medical companies, also called biotech or life sciences companies, from their offices in Amsterdam, the Netherlands. It's latest fund, Aescap 2.0, manages over 200 million euro and has a long term outperformance of its bench mark, the Nasdaq Biotech Index. Aescap 2.0 has the highest Morningstar rating (5-stars)
|
Open
|
biotech, fund management, life sciences
|
Open
|
Barbara Strozzilaan 101
|
Amsterdam
|
North Holland
|
NL
|
1083HN
|
|
Aescap Venture
|
|
Financial Services
|
private:aescapventure
|
218794
|
Dec 1st, 2020 12:00AM
|
Aescap
|
247
|
10.00
|
Open
|
Investment Management
|
Dec 1st, 2020 09:42AM
|
Dec 1st, 2020 09:42AM
|
Aescap invests in public medical companies, also called biotech or life sciences companies, from their offices in Amsterdam, the Netherlands. It's latest fund, Aescap 2.0, manages over 200 million euro and has a long term outperformance of its bench mark, the Nasdaq Biotech Index. Aescap 2.0 has the highest Morningstar rating (5-stars)
|
Open
|
biotech, fund management, life sciences
|
Open
|
Barbara Strozzilaan 101
|
Amsterdam
|
North Holland
|
NL
|
1083HN
|
|
Aescap Venture
|
|
Financial Services
|
private:aescapventure
|
218794
|
Nov 30th, 2020 12:00AM
|
Aescap
|
247
|
10.00
|
Open
|
Investment Management
|
Nov 30th, 2020 10:00AM
|
Nov 30th, 2020 10:00AM
|
Aescap invests in public medical companies, also called biotech or life sciences companies, from their offices in Amsterdam, the Netherlands. It's latest fund, Aescap 2.0, manages over 200 million euro and has a long term outperformance of its bench mark, the Nasdaq Biotech Index. Aescap 2.0 has the highest Morningstar rating (5-stars)
|
Open
|
biotech, fund management, life sciences
|
Open
|
Barbara Strozzilaan 101
|
Amsterdam
|
North Holland
|
NL
|
1083HN
|
|
Aescap Venture
|
|
Financial Services
|
private:aescapventure
|
218794
|
Nov 29th, 2020 12:00AM
|
Aescap
|
247
|
10.00
|
Open
|
Investment Management
|
Nov 29th, 2020 04:46PM
|
Nov 29th, 2020 04:46PM
|
Aescap invests in public medical companies, also called biotech or life sciences companies, from their offices in Amsterdam, the Netherlands. It's latest fund, Aescap 2.0, manages over 200 million euro and has a long term outperformance of its bench mark, the Nasdaq Biotech Index. Aescap 2.0 has the highest Morningstar rating (5-stars)
|
Open
|
biotech, fund management, life sciences
|
Open
|
Barbara Strozzilaan 101
|
Amsterdam
|
North Holland
|
NL
|
1083HN
|
|
Aescap Venture
|
|
Financial Services
|
private:aescapventure
|
218794
|
Nov 28th, 2020 12:00AM
|
Aescap
|
247
|
10.00
|
Open
|
Investment Management
|
Nov 28th, 2020 12:39PM
|
Nov 28th, 2020 12:39PM
|
Aescap invests in public medical companies, also called biotech or life sciences companies, from their offices in Amsterdam, the Netherlands. It's latest fund, Aescap 2.0, manages over 200 million euro and has a long term outperformance of its bench mark, the Nasdaq Biotech Index. Aescap 2.0 has the highest Morningstar rating (5-stars)
|
Open
|
biotech, fund management, life sciences
|
Open
|
Barbara Strozzilaan 101
|
Amsterdam
|
North Holland
|
NL
|
1083HN
|
|
Aescap Venture
|
|
Financial Services
|
private:aescapventure
|
218794
|
Nov 27th, 2020 12:00AM
|
Aescap
|
246
|
10.00
|
Open
|
Investment Management
|
Nov 27th, 2020 08:58AM
|
Nov 27th, 2020 08:58AM
|
Aescap invests in public medical companies, also called biotech or life sciences companies, from their offices in Amsterdam, the Netherlands. It's latest fund, Aescap 2.0, manages over 200 million euro and has a long term outperformance of its bench mark, the Nasdaq Biotech Index. Aescap 2.0 has the highest Morningstar rating (5-stars)
|
Open
|
biotech, fund management, life sciences
|
Open
|
Barbara Strozzilaan 101
|
Amsterdam
|
North Holland
|
NL
|
1083HN
|
|
Aescap Venture
|
|
Financial Services
|
private:aescapventure
|
218794
|
Nov 26th, 2020 12:00AM
|
Aescap
|
246
|
11.00
|
Open
|
Investment Management
|
Nov 26th, 2020 10:00AM
|
Nov 26th, 2020 10:00AM
|
Aescap invests in public medical companies, also called biotech or life sciences companies, from their offices in Amsterdam, the Netherlands. It's latest fund, Aescap 2.0, manages over 200 million euro and has a long term outperformance of its bench mark, the Nasdaq Biotech Index. Aescap 2.0 has the highest Morningstar rating (5-stars)
|
Open
|
biotech, fund management, life sciences
|
Open
|
Barbara Strozzilaan 101
|
Amsterdam
|
North Holland
|
NL
|
1083HN
|
|
Aescap Venture
|
|
Financial Services
|
private:aescapventure
|
218794
|
Nov 25th, 2020 12:00AM
|
Aescap
|
246
|
11.00
|
Open
|
Investment Management
|
Nov 25th, 2020 12:10PM
|
Nov 25th, 2020 12:10PM
|
Aescap invests in public medical companies, also called biotech or life sciences companies, from their offices in Amsterdam, the Netherlands. It's latest fund, Aescap 2.0, manages over 200 million euro and has a long term outperformance of its bench mark, the Nasdaq Biotech Index. Aescap 2.0 has the highest Morningstar rating (5-stars)
|
Open
|
biotech, fund management, life sciences
|
Open
|
Barbara Strozzilaan 101
|
Amsterdam
|
North Holland
|
NL
|
1083HN
|
|
Aescap Venture
|
|
Financial Services
|
private:aescapventure
|
218794
|
Nov 24th, 2020 12:00AM
|
Aescap
|
246
|
11.00
|
Open
|
Investment Management
|
Nov 24th, 2020 08:48AM
|
Nov 24th, 2020 08:48AM
|
Aescap invests in public medical companies, also called biotech or life sciences companies, from their offices in Amsterdam, the Netherlands. It's latest fund, Aescap 2.0, manages over 200 million euro and has a long term outperformance of its bench mark, the Nasdaq Biotech Index. Aescap 2.0 has the highest Morningstar rating (5-stars)
|
Open
|
biotech, fund management, life sciences
|
Open
|
Barbara Strozzilaan 101
|
Amsterdam
|
North Holland
|
NL
|
1083HN
|
|
Aescap Venture
|
|
Financial Services
|